Limitación del esfuerzo terapéutico

JB Gutiérrez, CR Casabona, P Gijón, J Júdez - Medicina clínica, 2001 - Elsevier
1. Desde el principio de no maleficencia: la contraindicación. Es el principio a utilizar por el
médico en su toma de decisiones sobre limitación de esfuerzos terapéuticos. El médico en …

Invasive pulmonary aspergillosis in the COVID‐19 era: An expected new entity

…, A Galar, MD García, DG de Viedma, P Gijón… - Mycoses, 2021 - Wiley Online Library
Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis (CAPA)
entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

[HTML][HTML] Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome

J Guinea, M Torres-Narbona, P Gijon, P Muñoz… - Clinical microbiology …, 2010 - Elsevier
We describe a large series of patients with chronic obstructive pulmonary disease (COPD)
and probable invasive pulmonary aspergillosis (IPA), and the risk factors and incidence of the …

Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis

J Rodríguez-Baño, E Picón, P Gijón… - Clinical infectious …, 2010 - academic.oup.com
Background There is little clinical information about community-onset bloodstream infections
(COBSIs) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli (…

Risk Factors and Prognosis of Nosocomial Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli

J Rodríguez-Bano, E Picón, P Gijón… - Journal of clinical …, 2010 - Am Soc Microbiol
Extended-spectrum-β-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is an
increasing cause of community and nosocomial infections worldwide. However, there is scarce …

[HTML][HTML] Combination of tocilizumab and steroids to improve mortality in patients with severe COVID-19 infection: a Spanish, multicenter, cohort study

…, R Llop-Rius, C Pedrós, P Gijón… - Infectious diseases and …, 2021 - Springer
Background We aimed to determine the impact of tocilizumab use on severe COVID-19 (coronavirus
disease 19) pneumonia mortality. Methods We performed a multicentre …

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

…, I Gutiérrez, M Ramírez, B Padilla, P Gijón… - HIV …, 2021 - Wiley Online Library
Objectives We compared the characteristics and clinical outcomes of hospitalized individuals
with COVID‐19 with [people with HIV (PWH)] and without (non‐PWH) HIV co‐infection in …

False-positive Aspergillus Antigenemia Due to Blood Product Conditioning Fluids

P Martín-Rabadán, P Gijón… - Clinical Infectious …, 2012 - academic.oup.com
The presence of Aspergillus antigens in blood transfusion components from different
manufacturers was analyzed. Galacomannans were found in transfused patients, pooled platelet …

[HTML][HTML] Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer

…, C Padilla, P Escribano, P Muñoz, B Padilla, P Gijón… - PloS one, 2013 - journals.plos.org
Methods based on real-time polymerase chain reaction (PCR) can speed up the diagnosis
of invasive aspergillosis but are limited by a lack of standardization. We evaluated the …

Resistance to voriconazole due to a G448S substitution in Aspergillus fumigatus in a patient with cerebral aspergillosis

T Pelaez, P Gijón, E Bunsow, E Bouza… - Journal of clinical …, 2012 - Am Soc Microbiol
A voriconazole-resistant isolate of Aspergillus fumigatus was recovered from an immunocompetent
patient receiving long-term antifungal therapy for cerebral aspergillosis. A G448S …